Search clinical trials for: Ketamine or placebo

Total 59671 results

Yan Qiu

Unknown

The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) (ECT)

Major Depressive Disorder | Depression, Unipolar | Depression, Bipolar | Manic-Depressive - Now Depressed

China
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY MDD)

Major Depressive Disorder | Treatment Resistant Depression

Austria, Germany, Italy, Spain, United Kingdom
HeNan Sincere Biotech Co., Ltd

Completed

A Study of CL-197 Capsules in Healthy Participants

HIV-1

China
Centre Hospitalier Universitaire de Charleroi
Centre Hospitalier Universitaire de Liege

Recruiting

Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome. (KESK-FIQ)

Fibromyalgia

Belgium
Zylorion Health

Terminated

Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression (ZYL-730-01)

Treatment Resistant Major Depressive Disorder

Canada
Shandong Suncadia Medicine Co., Ltd.

Active, not recruiting

Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects

Chronic Kidney Disease

China
Bridge Biotherapeutics, Inc.
Covance

Completed

Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Ulcerative Colitis

United States, Korea, Republic of, Poland, Ukraine
7TM Pharma A/S

Terminated

A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.

Obesity
Vertex Pharmaceuticals Incorporated

Completed

Study of VX-985 in Subjects With Chronic Hepatitis C

Chronic Hepatitis C

United States
Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States
University Hospital, Strasbourg, France

Unknown

Arteriopathy and Endothelial Function

Peripheral Arterial Disease

France
Shanghai Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Moderate to Severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd

Enrolling by invitation

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

Kidney Transplantation

China
University Hospital, Bonn

Active, not recruiting

An Exploratory Clinical Study on Autophagy and Multi-level Molecular Profiling During Spermidine Supplementation

Depression | Healthy

Germany
Alzheon Inc.
Quotient Clinical

Completed

Multiple Ascending Dose Study of ALZ-801

Alzheimer Disease

United Kingdom
Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

Early Parkinson Disease

United States
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis

Rheumatoid Arthritis

Canada, Russian Federation
University of South Florida

Completed

Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients (DUSTMITE)

ALLERGIC RHINITIS

United States
University Hospital, Ghent

Completed

A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares

Verrucae Vulgares

Belgium
Takeda

Completed

Single-Dose Study of MT203

Healthy Volunteers

Japan
Evolve BioSystems, Inc.

Terminated

The COLIC Study: Colonization of the Infant Gut With B. Infantis EVC001 to Reduce Symptoms of Colic (COLIC)

Infantile Colic

United States
Chinese PLA General Hospital
First Affiliated Hospital, Sun Yat-Sen University; Shengjing Hospital; First... and other collaborators

Not yet recruiting

Safety and Efficacy Evaluation of S (+) - Ketamine in Adults

Postoperative Pain | Anesthesia | Adults
Chinese PLA General Hospital
Shanghai Children's Medical Center; Beijing Children's Hospital; Southern Medical... and other collaborators

Enrolling by invitation

Safety and Efficacy Evaluation of S (+) - Ketamine in Children

Delirium | Postoperative Pain | Analgesia | Children | Acute Pain | Depression, Anxiety | Hyperalgesia | S-ketamine | Esketamine

China
Ling Dong

Recruiting

The Effect of S-ketamine Combined With Sufentanil for Postoperative Analgesia in Patients Following Cesarean Section

Cesarean Section | S-ketamine | Analgesia, Patient-Controlled

China
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

Bipolar Depression

Poland
Janssen Pharmaceutical K.K.

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression

Depression

Japan
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

Major Depressive Disorder

Poland
Janssen Research & Development, LLC

Completed

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States
Rigshospitalet, Denmark
Copenhagen Trial Unit, Center for Clinical Intervention Research

Recruiting

The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury (KETA-BID)

Traumatic Brain Injury | Subarachnoid Hemorrhage, Aneurysmal | Intracerebral Hemorrhage

Denmark
Peking University First Hospital

Recruiting

Analgesic Effects of Low-dose S-ketamine in Major Spine Fusion Surgery

Spine Fusion | Postoperative Analgesia | S-ketamine

China
Eye & ENT Hospital of Fudan University

Recruiting

Comparison of Esketamine-Propofol and Fentanyl-Propofol

Hemodynamics

China
Hellenic Institute for the Study of Sepsis

Completed

The Benefit of Bermekimab in Patients With Systemic Sclerosis

Scleroderma, Systemic

Greece
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Facioscapulohumeral Muscular Dystrophy

United States, Spain, Canada
Pfizer

Completed

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Psoriasis

Canada, United States, Japan, Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

Healthy Volunteers

Poland
Boston Pharmaceuticals

Completed

Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects

Healthy Participants

United Kingdom
Akros Pharma Inc.

Terminated

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

Diabetes Mellitus

United States
Nathaniel Jenkins

Completed

Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes

Mood | Caffeine | Exercise Performance | Energy Drink | Cardiovascular Safety

United States
University of Maryland, Baltimore
National Center for Complementary and Integrative Health (NCCIH)

Terminated

Safety of VSL#3 in Adult Asthmatics

Asthma

United States
Genexine, Inc.

Completed

Phase I Study GX-G3 in Healthy Subjects (GX-G3)

Healthy

Korea, Republic of
University of Sydney
Telethon Kids Institute; Bionet Co., Ltd; Technovalia; Institute for Clinical Pathology...

Completed

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (COVALIA)

SARS-CoV2 COVID-19

Australia
Janssen Research & Development, LLC

Completed

A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide

Major Depressive Disorder

United States
Lotus Clinical Research, LLC
iX Biopharma Ltd.

Completed

A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

Pain

United States
Barts & The London NHS Trust
University College, London; Queen Mary University of London

Completed

Bone Marrow Derived Adult Stem Cells for Acute Anterior Myocardial Infarction (REGEN-AMI)

Acute Myocardial Infarction

Switzerland, Denmark, United Kingdom
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers

Healthy

China
Labo'Life

Recruiting

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts (EVAsION)

Plantar Wart | Common Wart | Flat Wart

Belgium
Ohio University

Active, not recruiting

Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning

Metabolism

United States
Shanghai Mental Health Center
Changhai Hospital; Fudan University; Tongji Hospital; Shanghai 10th People's Hospital and other collaborators

Unknown

Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression

Generalized Anxiety Disorder | Major Depressive Disorder

China
Meshalkin Research Institute of Pathology of Circulation

Unknown

"ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction (ESTIMATION)

Heart Failure | Acute Myocardial Infarction

Russian Federation
Ornovi, Inc.

Withdrawn

A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects

Alopecia Areata

Australia

Search clinical trials for: Ketamine or placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations